Literature DB >> 31421818

Management of post-traumatic long bone defects: A comparative study based on long-term results.

Gen Wen1, Runhua Zhou2, Yanmao Wang2, Shengdi Lu2, Yimin Chai3, Huilin Yang4.   

Abstract

BACKGROUND: Reconstruction of post-traumatic long bone defects is a formidable problem. To date, the approaches for bony reconstruction remain controversial. Thus, we aimed to compare the different methods in the treatment of patients with post-traumatic long bone defects, based on the long-term functional and self-evaluation results.
METHODS: We retrospectively reviewed data on patients with post-traumatic long bone defects of the lower extremities from January 2006 to January 2015. The patients were divided into three groups according to the surgical method used to treat the defects (group 1, free vascularized fibular transfer; group 2, distraction osteogenesis; group 3, the induced membrane technique). Data including the complication rates, entire treatment period, long-term visual analog scale scores, and Sickness Impact Profile (SIP) scores during follow-up were recorded.
RESULTS: A total of 317 patients were included, with 106, 132, and 79 patients in groups 1, 2, and 3, respectively. The major complication rates were 22.6%, 25.8%, and 26.6% for the groups (P > 0.05), respectively. The mean treatment durations for bony defects, from surgery to non-protected weight-bearing, were 65.1, 46.5, and 56.6 weeks for each group, respectively. At 2 years postoperatively, the average SIP scores for each group were 10.5, 11.7, and 11.5, respectively (P > 0.05).
CONCLUSION: Patients who sustained long bone defects can be advised that either one of these three methods which typically results in long-term outcomes equivalent to others. LEVEL OF EVIDENCE: retrospective study.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Free vascularized fibular transfer; Ilizarov technique; Induced membrane technique; Long bone defects

Mesh:

Year:  2019        PMID: 31421818     DOI: 10.1016/j.injury.2019.07.029

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  6 in total

1.  In vivo study of polyurethane and tannin-modified hydroxyapatite composites for calvarial regeneration.

Authors:  Xinggui Tian; Xiaowei Yuan; Daxiong Feng; Min Wu; Yuping Yuan; Chuying Ma; Denghui Xie; Jinshan Guo; Chao Liu; Zhihui Lu
Journal:  J Tissue Eng       Date:  2020-11-21       Impact factor: 7.813

2.  A Systematic Review and Meta-Analysis of Combined Antibiotic Spacer with Ilizarov Methods in the Treatment of Infected Nonunion of Tibia.

Authors:  Zhibo Deng; Yuexi Mu; Xianding Sun; Yongqing Xu; Fubing Li; Liangjun Yin
Journal:  Biomed Res Int       Date:  2021-01-16       Impact factor: 3.411

3.  Evaluation of the efficacy of ipsilateral fibular transfer for reconstruction of large tibial defects in children: a retrospective study.

Authors:  SiYu Xu; YaoXi Liu; GuangHui Zhu; Kun Liu; Jin Tang; JiangYan Wu; An Yan; Fei Jiang; ShaSha Mo; HaiBo Mei
Journal:  J Orthop Surg Res       Date:  2022-03-05       Impact factor: 2.359

4.  A Case of Reconstruction of an Open Tibial Fracture (Gustilo-Anderson Type IIIB) With Severe Skin and Bone Loss Using Corticocancellous Bone Plugs From the Iliac Crest and an Ilizarov Frame.

Authors:  Spyridon Papagiannis; George Sinos; Ioannis Vrachnis; Stavros Balasis; Antonis Kouzelis
Journal:  Cureus       Date:  2022-02-23

Review 5.  Masquelet technique in military practice: specificities and future directions for combat-related bone defect reconstruction.

Authors:  Laurent Mathieu; Romain Mourtialon; Marjorie Durand; Arnaud de Rousiers; Nicolas de l'Escalopier; Jean-Marc Collombet
Journal:  Mil Med Res       Date:  2022-09-02

6.  Supercritical Carbon Dioxide Decellularized Bone Matrix Seeded with Adipose-Derived Mesenchymal Stem Cells Accelerated Bone Regeneration.

Authors:  Keng-Fan Liu; Rong-Fu Chen; Yun-Ting Li; Yun-Nan Lin; Dar-Jen Hsieh; Srinivasan Periasamy; Sin-Daw Lin; Yur-Ren Kuo
Journal:  Biomedicines       Date:  2021-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.